1. Cardiometabolic Disease, Merck Research Laboratories, Kenilworth, New Jersey;
2. Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio; and
3. Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas